Simon Barry J.

Simon Barry J. is listed in filings as Director at ImmunityBio, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to ImmunityBio, Inc. (IBRX) and Viracta Therapeutics, Inc. (VIRX). The current snapshot covers public activity from Jun 24, 2024 to Jun 5, 2026. Reported amounts are shown as $165.3K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.